Raike Robert S, Jinnah H A, Hess Ellen J
Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
NeuroRx. 2005 Jul;2(3):504-12. doi: 10.1602/neurorx.2.3.504.
Dystonia is a prevalent neurological disorder characterized by abnormal co-contractions of antagonistic muscle groups that produce twisting movements and abnormal postures. The disorder may be inherited, arise sporadically, or result from brain insult. Dystonia is a heterogeneous disorder because patients may exhibit focal or generalized symptoms associated with abnormalities in many brain regions including basal ganglia and cerebellum. Elucidating the pathogenic mechanisms underlying dystonia has therefore been challenging. Animal models of dystonia exhibit similar heterogeneity and are useful for understanding pathogenesis. The neurochemical and neurophysiological abnormalities in rodents with idiopathic generalized dystonia suggest that dysfunctional output from basal ganglia, cerebellum, or from multiple systems is the cause of motor dysfunction. Findings from drug- or toxin-induced dystonia in rodents and nonhuman primates mirror the genetic models. The parallels between dystonia in humans and animals suggest that the models will continue to prove useful in determining pathogenesis. Furthermore, detailed characterization of the existing models of dystonia and the development of new models hold promise for the identification of novel therapeutics.
肌张力障碍是一种常见的神经系统疾病,其特征是拮抗肌群异常共同收缩,产生扭转运动和异常姿势。该疾病可能是遗传性的,也可能是散发性的,或者由脑部损伤引起。肌张力障碍是一种异质性疾病,因为患者可能表现出与包括基底神经节和小脑在内的许多脑区异常相关的局灶性或全身性症状。因此,阐明肌张力障碍的致病机制具有挑战性。肌张力障碍的动物模型表现出类似的异质性,有助于理解发病机制。特发性全身性肌张力障碍啮齿动物的神经化学和神经生理学异常表明,基底神经节、小脑或多个系统的功能失调输出是运动功能障碍的原因。啮齿动物和非人灵长类动物药物或毒素诱导的肌张力障碍研究结果与遗传模型相似。人类和动物肌张力障碍之间的相似之处表明,这些模型将继续在确定发病机制方面发挥作用。此外,对现有肌张力障碍模型的详细表征和新模型的开发有望确定新的治疗方法。